99 related articles for article (PubMed ID: 32581046)
1. Correction: Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581046
[No Abstract] [Full Text] [Related]
2. Pre-existing antitherapeutic antibodies against the Fc region of the hu14.18K322A mAb are associated with outcome in patients with relapsed neuroblastoma.
Goldberg JL; Navid F; Hank JA; Erbe AK; Santana V; Gan J; de Bie F; Javaid AM; Hoefges A; Merdler M; Carmichael L; Kim K; Bishop MW; Meager MM; Gillies SD; Pandey JP; Sondel PM
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169872
[TBL] [Abstract][Full Text] [Related]
3. A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma.
Furman WL; Federico SM; McCarville MB; Shulkin BL; Davidoff AM; Krasin MJ; Sahr N; Sykes A; Wu J; Brennan RC; Bishop MW; Helmig S; Stewart E; Navid F; Triplett B; Santana VM; Bahrami A; Anthony G; Yu AL; Hank J; Gillies SD; Sondel PM; Leung WH; Pappo AS
Clin Cancer Res; 2019 Nov; 25(21):6320-6328. PubMed ID: 31601569
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma.
Anghelescu DL; Goldberg JL; Faughnan LG; Wu J; Mao S; Furman WL; Santana VM; Navid F
Pediatr Blood Cancer; 2015 Feb; 62(2):224-228. PubMed ID: 25382742
[TBL] [Abstract][Full Text] [Related]
5. 64Cu-p-NH2-Bn-DOTA-hu14.18K322A, a PET radiotracer targeting neuroblastoma and melanoma.
Vavere AL; Butch ER; Dearling JL; Packard AB; Navid F; Shulkin BL; Barfield RC; Snyder SE
J Nucl Med; 2012 Nov; 53(11):1772-8. PubMed ID: 23064212
[TBL] [Abstract][Full Text] [Related]
6. Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu14.18K322A.
Tse BC; Navid F; Billups CA; O'Donnell T; Hoehn ME
J AAPOS; 2015 Apr; 19(2):112-5. PubMed ID: 25818285
[TBL] [Abstract][Full Text] [Related]
7. Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma.
Otto M; Barfield RC; Martin WJ; Iyengar R; Leung W; Leimig T; Chaleff S; Gillies SD; Handgretinger R
Clin Cancer Res; 2005 Dec; 11(23):8486-91. PubMed ID: 16322312
[TBL] [Abstract][Full Text] [Related]
8. A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
Osenga KL; Hank JA; Albertini MR; Gan J; Sternberg AG; Eickhoff J; Seeger RC; Matthay KK; Reynolds CP; Twist C; Krailo M; Adamson PC; Reisfeld RA; Gillies SD; Sondel PM;
Clin Cancer Res; 2006 Mar; 12(6):1750-9. PubMed ID: 16551859
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Phase II Study.
Shusterman S; Naranjo A; Van Ryn C; Hank JA; Parisi MT; Shulkin BL; Servaes S; London WB; Shimada H; Gan J; Gillies SD; Maris JM; Park JR; Sondel PM
Clin Cancer Res; 2019 Oct; 25(20):6044-6051. PubMed ID: 31358541
[TBL] [Abstract][Full Text] [Related]
10. Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy.
Neal ZC; Yang JC; Rakhmilevich AL; Buhtoiarov IN; Lum HE; Imboden M; Hank JA; Lode HN; Reisfeld RA; Gillies SD; Sondel PM
Clin Cancer Res; 2004 Jul; 10(14):4839-47. PubMed ID: 15269160
[TBL] [Abstract][Full Text] [Related]
11. Enhancing both CT imaging and natural killer cell-mediated cancer cell killing by a GD2-targeting nanoconstruct.
Jiao P; Otto M; Geng Q; Li C; Li F; Butch ER; Snyder SE; Zhou H; Yan B
J Mater Chem B; 2016 Jan; 4(3):513-520. PubMed ID: 27087966
[TBL] [Abstract][Full Text] [Related]
12. High specificity targeting and detection of human neuroblastoma using multifunctional anti-GD2 iron-oxide nanoparticles.
Baiu DC; Artz NS; McElreath MR; Menapace BD; Hernando D; Reeder SB; Grüttner C; Otto M
Nanomedicine (Lond); 2015 Oct; 10(19):2973-2988. PubMed ID: 26420448
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with interleukin-2 and antitumor monoclonal antibodies.
Sondel PM; Hank JA
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S121-7. PubMed ID: 9457407
[TBL] [Abstract][Full Text] [Related]
14. Direct demonstration of binding of aggregated mouse IgG1 to the 40-kDa Fc receptor for IgG (Fc gamma RII) in both high and low responders.
Möst J; Glassl H; Gattringer C; Neumayer HP; Schulz TF; Dierich MP; Huber H
Immunol Lett; 1992 Apr; 32(2):159-65. PubMed ID: 1377171
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of four monoclonal antibodies against HLA-B27 for their reliability in HLA-B27 typing with flow cytometry (FC): comparison with the classic microlymphocytotoxic test (MLCT).
Neumüller J; Schwartz DW; Dauber E; Mayr WR
Cytometry; 1996 Sep; 26(3):209-15. PubMed ID: 8889393
[TBL] [Abstract][Full Text] [Related]
16. Relationships between epitopes on IgE recognized by defined monoclonal antibodies and by the FC epsilon receptor on basophils.
Baniyash M; Eshhar Z; Rivnay B
J Immunol; 1986 Jan; 136(2):588-93. PubMed ID: 2416816
[TBL] [Abstract][Full Text] [Related]
17. Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells.
Talleur AC; Triplett BM; Federico S; Mamcarz E; Janssen W; Wu J; Shook D; Leung W; Furman WL
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1910-1917. PubMed ID: 28733263
[TBL] [Abstract][Full Text] [Related]
18. Mapping epitopes of human Fc gamma RII (CDw32) with monoclonal antibodies and recombinant receptors.
Ierino FL; Hulett MD; McKenzie IF; Hogarth PM
J Immunol; 1993 Mar; 150(5):1794-803. PubMed ID: 7679695
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid factors may bear the internal image of the Fc gamma-binding protein of herpes simplex virus type 1.
Tsuchiya N; Williams RC; Hutt-Fletcher LM
J Immunol; 1990 Jun; 144(12):4742-8. PubMed ID: 2161877
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous blockade of Fc gamma receptors and indirect labeling of mouse lymphocytes by the selective detection of allotype-restricted epitopes on the kappa chain of rat monoclonal antibodies.
Balogh P; Tew JG; Szakal AK
Cytometry; 2002 Feb; 47(2):107-10. PubMed ID: 11813200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
